- Home
- VNDA vs NREF Comparison
VNDA vs NREF Comparison
Compare VNDA & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- NREF
- Stock Information
- Founded
- VNDA 2002
- NREF 2019
- Country
- VNDA United States
- NREF United States
- Employees
- VNDA N/A
- NREF N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- NREF Real Estate Investment Trusts
- Sector
- VNDA Health Care
- NREF Real Estate
- Exchange
- VNDA Nasdaq
- NREF Nasdaq
- Market Cap
- VNDA 282.8M
- NREF 275.2M
- IPO Year
- VNDA 2006
- NREF 2020
- Fundamental
- Price
- VNDA $4.98
- NREF $15.85
- Analyst Decision
- VNDA Strong Buy
- NREF Hold
- Analyst Count
- VNDA 2
- NREF 4
- Target Price
- VNDA $16.50
- NREF $15.00
- AVG Volume (30 Days)
- VNDA 751.6K
- NREF 37.3K
- Earning Date
- VNDA 05-07-2025
- NREF 05-01-2025
- Dividend Yield
- VNDA N/A
- NREF 12.76%
- EPS Growth
- VNDA N/A
- NREF N/A
- EPS
- VNDA N/A
- NREF 1.32
- Revenue
- VNDA $198,772,000.00
- NREF $73,164,000.00
- Revenue This Year
- VNDA $14.36
- NREF N/A
- Revenue Next Year
- VNDA $44.53
- NREF $43.59
- P/E Ratio
- VNDA N/A
- NREF $12.19
- Revenue Growth
- VNDA 3.18
- NREF 224.04
- 52 Week Low
- VNDA $3.71
- NREF $12.63
- 52 Week High
- VNDA $6.75
- NREF $18.09
- Technical
- Relative Strength Index (RSI)
- VNDA 58.23
- NREF 47.72
- Support Level
- VNDA $4.84
- NREF $15.75
- Resistance Level
- VNDA $5.10
- NREF $16.31
- Average True Range (ATR)
- VNDA 0.24
- NREF 0.50
- MACD
- VNDA 0.02
- NREF -0.03
- Stochastic Oscillator
- VNDA 76.40
- NREF 20.83
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a real estate investment trust. It provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.